Large-cap Industrials company Thermo Fisher Scientific has moved 1.5% so far today on a volume of 1,398,653, compared to its average of 1,704,682. In contrast, the S&P 500 index moved -1.0%.
Thermo Fisher Scientific trades -11.69% away from its average analyst target price of $627.09 per share. The 23 analysts following the stock have set target prices ranging from $520.0 to $698.0, and on average have given Thermo Fisher Scientific a rating of buy.
If you are considering an investment in TMO, you'll want to know the following:
-
Thermo Fisher Scientific's current price is 184.9% above its Graham number of $194.39, which implies that at its current valuation it does not offer a margin of safety
-
Thermo Fisher Scientific has moved -6.0% over the last year, and the S&P 500 logged a change of 10.0%
-
Based on its trailing earnings per share of 14.65, Thermo Fisher Scientific has a trailing 12 month Price to Earnings (P/E) ratio of 37.8 while the S&P 500 average is 15.97
-
TMO has a forward P/E ratio of 22.4 based on its forward 12 month price to earnings (EPS) of $24.72 per share
-
The company has a price to earnings growth (PEG) ratio of 3.44 — a number near or below 1 signifying that Thermo Fisher Scientific is fairly valued compared to its estimated growth potential
-
Its Price to Book (P/B) ratio is 4.88 compared to its sector average of 3.78
-
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally.
-
Based in Waltham, the company has 130,000 full time employees and a market cap of $213.6 Billion. Thermo Fisher Scientific currently returns an annual dividend yield of 0.2%.